An experimental cancer treatment regimen is achieving full remissions in some patients with aggressive B-cell lymphoma, researchers report. 

The five-drug combination does not include chemotherapy. Rather, it simultaneously zeroes in on several molecular pathways that diffuse large B-cell lymphoma (DLBCL) tumors rely on to survive. B-cell lymphoma is a cancer of cells in the body's i...

Research suggests that tattoo ink spurs inflammatory changes that might contribute to the development of lymphoma.

The findings are early, however, and more study must be done to confirm any links between tattooing and the blood cancer, Swedish researchers stressed.

"People will likely want to continue to express their identity through tattoos, and therefore it is very important tha...

An older drug used in a new way could open the path for more patients with potentially deadly blood cancers to receive a lifesaving stem cell transplant, a new study finds.

The drug, cyclophosphamide, could help patients receive a stem cell transplant even if the donor isn't a relative and only partially matches their blood type, researchers report.

Blood cancer patients had a high ...

Polycythemia vera is a rare form of blood cancer with few good treatment options, but that may soon change based on the results of a new clinical trial.

An injected experimental drug called rusfertide appears effective in reducing the excess production of red blood cells that's a hallmark of the disease.

"Rusfertide appears to represent a significant step forward in treating polycyt...

CT scans are significantly linked to an increased risk of blood cancers in young people, a major multinational study has found.

Analysis of data from nearly 1 million people under 22 who underwent at least one CT scan found a strong and clear link between exposure to the scans' radiation and blood cancers, according to findings published Nov. 9 in the journal